feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug",https://benzinga.com/general/biotech/21/09/23151661/the-daily-biotech-pulse-abbvies-migraine-drug-okd-by-fda-amicus-spins-off-gene-therapy-business-g,https://j.mp/3kXQ5Ml
